Jiajie Luan

Dr. Jiajie Luan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Phytomedicine
Verified
Journal Article
Closed access
ZXZhenyu Xu
Zhenyu Xu
LCLu Chen
Lu Chen
ZXZhangang Xiao
Zhangang Xiao
YZYanhong Zhu
Yanhong Zhu
HJHui Jiang
Hui Jiang
JSJing Shen
Jing Shen

11 April 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
DZDexi Zhou
Dexi Zhou
KYKui Yang
Kui Yang
LCLu Chen
Lu Chen
WZWen Zhang
Wen Zhang
ZXZhenyu Xu
Zhenyu Xu
JLJiajie Luan
Jiajie Luan
Promising landscape for regulating macrophage polarization: epigenetic viewpoint Promising landscape for regulating macrophage polarization: epigenetic viewpoint

10 July 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SWSheng Wang
Sheng Wang
SGSongsen Gao
Songsen Gao
DZDexi Zhou
Dexi Zhou
XQXueyi Qian
Xueyi Qian
JLJiajie Luan
Jiajie Luan
XLXiongwen Lv
Xiongwen Lv

28 January 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
DZDexi Zhou
Dexi Zhou
YWYaqin Wang
Yaqin Wang
LCLu Chen
Lu Chen
LJLeijuan Jia
Leijuan Jia
JYJie Yuan
Jie Yuan
JLJiajie Luan
Jiajie Luan
Evolving roles of circadian rhythms in liver homeostasis and pathology

27 July 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
SWSheng Wang
Sheng Wang
SGSongsen Gao
Songsen Gao
YLYueran Li
Yueran Li
XQXueyi Qian
Xueyi Qian
JLJiajie Luan
Jiajie Luan
XLXiongwen Lv
Xiongwen Lv
Chemokine receptors are members of the G protein-coupled receptor superfamily, which together with chemokine ligands form chemokine networks to regulate various cellular functions, immune and physiological processes. These receptors are closely related to cell movement and thus play a vital role in several physiological and pathological processes that require regulation of cell migration. CXCR4, one of the most intensively studied chemokine receptors, is involved in many functions in addition to immune cells recruitment and plays a pivotal role in the pathogenesis of liver disease. Aberrant CXCR4 expression pattern is related to the migration and movement of liver specific cells in liver disease through its cross-talk with a variety of significant cell signaling pathways. An in-depth understanding of CXCR4-mediated signaling pathway and its role in liver disease is critical to identifying potential therapeutic strategies. Current therapeutic strategies for liver disease mainly focus on regulating the key functions of specific cells in the liver, in which the CXCR4 pathway plays a crucial role. Multiple challenges remain to be overcome in order to more effectively target CXCR4 pathway and identify novel combination therapies with existing strategies. This review emphasizes the role of CXCR4 and its important cell signaling pathways in the pathogenesis of liver disease and summarizes the targeted therapeutic studies conducted to date.

13 May 2016 in OncoImmunology
Verified
Journal Article
Open access
ZXZhenyu Xu
Zhenyu Xu
JSJing Shen
Jing Shen
MWMaggie Haitian Wang
Maggie Haitian Wang
TYTao YI
Tao YI
YYYangyang Yu
Yangyang Yu
ZXZhangang Xiao
Zhangang Xiao
The B7 gene family has crucial roles in the regulation of adaptive cellular immunity. In cancer, deregulation of co-inhibitory B7 molecules is associated with reduced antitumor immunity and cancer immune evasion. FDA approval of cancer immunotherapy antibodies against cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death-1 (PD-1)—both ligands of the B7 family—demonstrate the impact of these checkpoint regulators in cancer. Using data from cBioPortal, we performed comprehensive molecular profiling of the 10 currently known B7 family proteins in 105 different cancers. B7 family members were amplified in breast cancer: with B7 mRNA levels upregulated in a cohort of 1,098 patients with all types of breast cancer and in 82 patients with triple-negative breast cancer. Promoter methylation analysis indicated an epigenetic basis for deregulation of certain B7 family genes in breast cancer. Moreover, patients with B7-H6 genomic alterations had significantly worse overall survival, and certain clinical attributes were associated with B7-H6 expression, which indicates that B7-H6 may be a potential target for breast cancer immunotherapy. Finally, using network analysis (based on data from cBioportal), we identified BTLA, MARCH8, PLSCR1 and SMAD3 as potentially involved in T cell signaling under regulation of B7 family proteins.